Bio-Connect

Phosphotyrosine antibody [PY20] (Biotin)

GTX16388
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityOther Species
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Phosphotyrosine antibody [PY20] (Biotin)
  • Delivery Days Customer
    9
  • Antibody Specificity
    Clone PY20 specifically recognizes phosphorylated tyrosine residues and does not react with phosphorylated threonine or serine residues.
  • Application Supplier Note
    ELISA: 1/5000. ICC: 1/500. WB: 1/5000. IHC: 1/500. Optimal dilutions/concentrations should be determined by the end user.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    PY20
  • Concentration
    1 mg/ml
  • Conjugate
    Biotin
  • Host
    Mouse
  • Isotype
    IgG2b
  • Scientific Description
    The role of tyrosine phosphorylation in transduction of the mitogenic signal from transmembrane receptors and in transformation by oncogene tyrosine kinases has been the subject of intense investigation for several years. While the phosphorylation of specific tyrosine residues has been shown to be a primary mechanism of signal transduction during normal mitogenesis, cell cycle progression and oncogenic transformation, its role in other areas such as differentiation and gap junction communication, is a matter of active and ongoing research.
  • Reactivity
    Other Species
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Extracellular-signal regulated kinase 8 of Trypanosoma brucei uniquely phosphorylates its proliferating cell nuclear antigen homolog and reveals exploitable properties. Valenciano AL et al., 2016 Oct 17, Cell Cycle
    Read more
  • OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma. Wang TH et al., 2016 Apr, Mol Carcinog
    Read more